Indication

Idiopathic short stature

Idiopathic short stature refers to extreme growth failure in pediatric patients whose standing height falls significantly below the normal range—typically defined as more than 2 to 2.25 standard deviations below the population mean for age, sex, and demographic cohort. Read more about Idiopathic short stature

12 drugs 6 manufacturers

Advertisement

Drugs that treat it

Common Idiopathic short stature therapies.

Showing 10–12 of 12 drugs

Filter & compare in the drug finder →Opens the drug finder with Idiopathic short stature preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Idiopathic short stature.

Idiopathic short stature refers to extreme growth failure in pediatric patients whose standing height falls significantly below the normal range—typically defined as more than 2 to 2.25 standard deviations below the population mean for age, sex, and demographic cohort.

It affects the musculoskeletal and endocrine-regulated growth systems, representing a heterogeneous clinical diagnosis of exclusion after systemic illness, nutritional deficiency, chromosomal anomalies, skeletal dysplasias, and classic growth hormone deficiency have been ruled out.

Patients characteristically exhibit normal baseline and stimulated growth hormone secretion, proportionate physical features, and absence of primary endocrine abnormalities, often resulting from subtle multifactorial genetic variations affecting the growth plate or the growth hormone–insulin-like growth factor axis.

Personalize your experience

Follow Idiopathic short stature and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it